Tables

Table TDI-1. Data sources for data on clients entering treatment in 2004

Table TDI-2. Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2004 – Part (i) Total numbers of new clients entering treatment

Table TDI-2. Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2004 – Part (ii) Total numbers of all clients entering treatment

Table TDI-2. Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2004 – Part (iii) Numbers of treatment units covered for reporting clients entering treatment

Table TDI-2. Numbers of clients entering treatment and numbers of reporting treatment centres, 1996 to 2004 – Part (iv) Types of units covered for reporting clients entering treatment

Table TDI-3. Distribution by primary drug used of new clients entering treatment, 1993 to 2004 – Part (i) Percentage of new clients using heroin

Table TDI-3. Distribution by primary drug used of new clients entering treatment, 1993 to 2004 – Part (ii) Percentage of new clients using cocaine

Table TDI-3. Distribution by primary drug used of new clients entering treatment, 1993 to 2004 – Part (iii) Percentage of new clients using cannabis

Table TDI-3. Distribution by primary drug used of new clients entering treatment, 1993 to 2004 – Part (iv) Percentage of new clients using stimulants (amphetamines and MDMA)

Table TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (i) Demographics and injecting status

Table TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (ii) Primary drug type used (percentage of new clients using) and of those, the percentage injecting it

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (i) Demographics and injecting status of all clients entering treatment

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (ii) Primary drug type used by clients (percent of all clients) and of those, the percent injecting it

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (iii) Demographics and injecting status of all men entering treatment

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (iv) Demographics and injecting status of all women entering treatment

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (v) Primary drug type used by male clients (percent of all male clients)

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (vi) Primary drug type used by female clients (percent of all female clients)

Table TDI-6. Trends in gender distribution among new clients entering treatment from 1992 to 2004 (expressed as males/females ratio)

Table TDI-7. Incidence of treatment demands for drug use: new clients entering treatment in 2004 (rate per 100 000 population in 2005)

Table TDI-8. Number of cases covered by the treatment demand indicator schedule reports: new clients and all clients entering treatment in 2004, by type of treatment centre

Table TDI-9. Clients entering outpatient treatment: mean age and gender distribution among new and all clients in 2004

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (i) Summary of age distribution (row percentage) for each primary drug type

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (ii) Distribution of primary drug used (column percentage) in each age group

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (iii) Number of clients using opioids as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (iv) Number of clients using cocaine (CIH and 'crack') as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (v) Number of clients using other stimulants as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (vi) Number of clients using hallucinogens as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (vii) Number of clients using hypnotics and sedatives as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (viii) Number of clients using volatile inhalants as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (ix) Number of clients using cannabis as primary drug

Table TDI-10. New clients entering outpatient treatment: age and primary drug at treatment in 2004 for those countries supplying data – Part (x) Number of clients using other drugs as primary drugs

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (i) Summary of distribution of age at first use (row percentage) for each primary drug type

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (ii) Summary of distribution of primary drug used (column percentages) in each age group

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (iii) Number of clients using opiates as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (iv) Number of clients using cocaine as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (v) Number of clients using stimulants as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (vi) Number of clients using Hypnotics and sedatives as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data. – Part (vii) Number of clients using hallucinogens as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (viii) Number of clients using volatile inhalants as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (ix) Number of clients using cannabis as primary drug

Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (x) Number of clients using other drugs as primary drugs

Table TDI-12. New clients entering outpatient treatment: distribution of educational level (percentage) in 2004 for countries reporting data

Table TDI-13. New clients entering outpatient treatment: distribution (percentage) of labour status in 2004 for countries supplying data

Table TDI-14. New clients entering outpatient treatment: distribution (percentage) by accommodation arrangements (persons with whom the client is living) in 2004, for countries submitting data

Table TDI-15. New clients entering outpatient treatment: living conditions in 2004 for countries supplying data

Table TDI-16. New clients entering outpatient treatment: distribution (percent) by source of referral in 2004 for countries supplying data

Table TDI-17. Route of administration of primary drug among new outpatient clients in 2004 – Part (i) Percentage among clients with opioids as primary drug

Table TDI-17. Route of administration of primary drug among new outpatient clients in 2004 – Part (ii) Percentage among clients with cocaine as primary drug

Table TDI-17. Route of administration of primary drug among new outpatient clients in 2004 – Part (iii) Percentage among clients with stimulants as primary drug

Table TDI-17. Route of administration of primary drug among new outpatient clients in 2004 – Part (iv) Percentage among clients with hypnotics and sedatives as primary drug

Table TDI-18. Frequency of use of primary drug among new outpatient clients in 2004 – Part (i) Percentage distribution among clients with opioids as primary drug

Table TDI-18. Frequency of use of primary drug among new outpatient clients in 2004 – Part (ii) Percentage distribution among clients with cannabis as primary drug

Table TDI-19. New and all clients entering outpatient treatment: distribution by primary drug at treatment in 2004 for those countries supplying data – Part (i) New clients

Table TDI-19. New and all clients entering outpatient treatment: distribution by primary drug at treatment in 2004 for those countries supplying data – Part (ii) All clients

Table TDI-20. Unemployment rates among new clients entering outpatient treatment in 2004 for countries providing data and in the general population aged 15 to 64 years in 2005

Table TDI-21. Gender ratio (ratio of males to females) among new and all clients entering outpatient treatment by primary drug (opioids, cannabis, cocaine, other stimulants) in 2004 for countries providing data – Part (i) Among new clients entering outpatient treatment

Table TDI-22. New clients entering outpatient treatment for primary use of amphetamines, ecstasy and other stimulants in 2004 for countries supplying data

Table TDI-23. New clients entering outpatient treatment: distribution of secondary drug used at treatment in 2004: average for those EU countries supplying data

Table TDI-24. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2004: the combination of cannabis, opioids, cocaine or other stimulants as primary drug type with a secondary drug – Part (i) Most frequent combination of the primary drug with the stated types of secondary drug (percentage)

Table TDI-24. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2004: the combination of cannabis, opioids, cocaine or other stimulants as primary drug type with a secondary drug – Part (i) All clients with opioids as primary drug: numbers reporting the stated drug as secondary

Table TDI-24. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2004: the combination of cannabis, opioids, cocaine or other stimulants as primary drug type with a secondary drug – Part (iii) All clients with cocaine as primary drug type: numbers reporting the stated drugs as secondary

Table TDI-24. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2004: the combination of cannabis, opioids, cocaine or other stimulants as primary drug type with a secondary drug – Part (iv) All clients with cannabis as primary drug: numbers reporting the stated drug as secondary

Table TDI-24. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2004: the combination of cannabis, opioids, cocaine or other stimulants as primary drug type with a secondary drug – Part (v) All clients with stimulants other than cocaine as primary drug type: numbers reporting the stated drugs as secondary

Table TDI-25. All clients entering outpatient and inpatient treatment centres by main drug for which they ask for treatment for those countries supplying data in 2004

Table TDI-26. All clients entering outpatient treatment for opioids by type of opioid misused for countries supplying data in 2004

Table TDI-27. New clients entering outpatient treatment for primary use of cocaine CIH and crack in 2004 for countries supplying data

Table TDI-28. Mean age of new outpatient clients in 2004 by gender and by main drug: overall EU averages for countries reporting data

Table TDI-29. Source of referral among new clients entering outpatient treatment: overall distribution (percent) by gender for EU countries that supplied data in 2004

Table TDI-30. Mean age at first use among new outpatient clients in 2004 by gender and by main drug: overall EU averages for countries supplying data

Table TDI-31. Gender ratio (ratio of males to females) among all clients entering treatment in 2004 for countries providing data and among drug related deaths in 2004 or most recent year available

Table TDI-32. Gender ratio (ratio of males to females) among all clients entering outpatient treatment by educational level in 2004 for countries reporting data

Table TDI-33. Gender ratio (ratio of males to females) in the route of administration of opiates, cocaine, stimulants among new outpatient clients in 2004 – Part (i) Summary of EU ratios for countries supplying data

Table TDI-33. Gender ratio (ratio of males to females) in the route of administration of opiates, cocaine, stimulants among new outpatient clients in 2004 – Part (ii) Opiates

Table TDI-33. Gender ratio (ratio of males to females) in the route of administration of opiates, cocaine, stimulants among new outpatient clients in 2004 – Part (iii) Cocaine

Table TDI-33. Gender ratio (ratio of males to females) in the route of administration of opiates, cocaine, stimulants among new outpatient clients in 2004 – Part (iv) Stimulants

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (i) EU summary for all drugs

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (ii) Opiates

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (iii) Cocaine

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (iv) Stimulants

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (v) Hypnotics and sedatives

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (vi) Hallucinogens

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (vii) Volatile inhalants

Table TDI-34. Gender ratio (ratio of males to females) among new outpatient clients by frequency of use of main drug in 2004, in the 30 days before starting treatment – Part (viii) Cannabis

Table TDI-35. Gender ratio (ratio of males to females) among new outpatient clients by secondary drug most used by country in 2004

Table TDI-36. Gender ratio (ratio of males to females) among all clients entering outpatient treatment by labour status in 2004 for countries reporting data

Table TDI-37. Gender ratio (ratio of males to females) among all clients entering outpatient treatment by living status in 2004 for countries reporting data

Table TDI-38. Gender ratio (ratio of males to females) among all clients entering outpatient treatment by categories of persons with whom they are living for countries reporting data, 2004

Table TDI-40. Unemployment rates among all males and females outpatient clients by country in 2004

Table TDI-41. Gender distribution of new and all clients entering treatment in 2004 or most recent year available in all types of treatment centres – Part (i) Gender ratio (ratio of males to females) among new clients

Table TDI-41. Gender distribution of new and all clients entering treatment in 2004 or most recent year available in all types of treatment centres – Part (ii) Gender ratio (ratio of males to females) among all clients

Table TDI-42. Gender ratio (ratio of males to females) among new and all clients entering outpatient treatment by age group in 2004 for countries providing data – Part (i) New clients

Table TDI-42. Gender ratio (ratio of males to females) among new and all clients entering outpatient treatment by age group in 2004 for countries providing data – Part (i) All clients